Harvard Bioscience
HBIO
HBIO
63 hedge funds and large institutions have $55.8M invested in Harvard Bioscience in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 26 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
31% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 26
Holders
63
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.14M | |
| 2 | +$1.2M | |
| 3 | +$379K | |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$274K |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$260K |
Top Sellers
| 1 | -$1.36M | |
| 2 | -$702K | |
| 3 | -$581K | |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$184K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$174K |